The Largest Deals, Fundraising and Exits of 2016 in European Biotech
Curious about which technologies have attracted the most cash in biotech finance this year? Here's a…
26/12/2016 - 5 minutes
CRISPR Therapeutics
The 8 Biggest Biotech Medical Fails of 2016 in Europe
Although 2016 has brought plenty of good news in medical advances, biotech is an industry…
23/12/2016 - 5 minutes
UPDATE: No Clear Winner in the CRISPR Patent Battle
Today marks an inflection point in the future of medicine: both parties fighting for the…
08/12/2016 - 3 minutes
How much of a Gamble is Investing in CRISPR?
CRISPR is going to change a lot in the life science industry and is perceived…
15/11/2016 - 4 minutes
CRISPR Thx’ surprisingly low IPO… why are Investors Discouraged?
Troubled waters in the CRISPR field: CRISPR Therapeutics' IPO hits an unexpectedly low price. It…
20/10/2016 - 2 minutes
€350M CRISPR Joint Venture now has a Name and an Office
Bayer and CRISPR Therapeutics have invested $373M in a joint venture, Casebia, as the latest…
23/08/2016 - 3 minutes
CRISPR Therapeutics increases its Series B to a Massive €125M
Everyone wants to invest in CRISPR Therapeutics, it seems. The Basel and Cambridge, US biotech…
27/06/2016 - 2 minutes
CRISPR Thx in yet another Collaboration, this time for Muscle Dystrophy
CRISPR Therapeutics has struck a deal with Anagenesis Biotechnologies, which has key technology for muscle…
10/06/2016 - 3 minutes
Wow, Europe’s leading CRISPR Biotech signs monster €2.29 Billion Deal
CRIPSR's hype is not going down yet. CRIPSR/Cas9 or Cpf1 is a revolutionising gene editing…
26/10/2015 - 2 minutes
CRISPR Patent war to End after the Discovery of a New Editing Protein other than Cas9?
CRISPR is already revolutionizing Biotechnology. However, like every biotech revolution, there then follows a patent…
30/09/2015 - 3 minutes
CRISPR Therapeutics reinforces its Team with Top Executives from Pfizer and McKinsey
A new strategic movement in the hot CRISPR field: CRISPR Therapeutics ramps up its leadership…
12/08/2015 - 2 minutes
Gene-editing Technology war continues while CRISPR Therapeutics raised €79.5M
As the CRISPR-Cas9 war still goes on, CRISPR Therapeutics closed a Series A and B…
30/04/2015 - 2 minutes
